2 stories mentioning HKG:6622Updated 19d ago
Every FINWIRES story that references HKG:6622, newest first.
Zhaoke Ophthalmology's (HKG:6622) registration application for Atropine Sulfate Eye Drops was accepted for evaluation by the Therapeutic Goods Administration of Australia, according to a Monday Hong Kong bourse filing.The drug is for slowing the progression of myopia in children.
Zhaoke Ophthalmology (HKG:6622) entered into a distribution and supply agreement with Erlangga Edi Laboratories to commercialize CsA Ophthalmic Gel in Indonesia, according to a Friday Hong Kong bourse filing.Under the agreement, the ophthalmic drug maker granted Erlangga exclusive rights to register, import, promote, distribute, market, and sell the dry eye disease drug in Indonesia.The firm will receive an upfront payment and additional milestone payments based on specific achievements.
